Israel Englander Grifols Sa Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2025 May 15, 2025	SELL	$6.62 - $8.71 $754,680 - $992,940	-114,000 Reduced 76.0%	36,000 $255,000
Q4 2024 Feb 14, 2025	BUY	$6.99 - $9.55 $1.05 Million - $1.43 Million	150,000 New	150,000 $1.12 Million
Q2 2024 Aug 14, 2024	SELL	$6.27 - $7.7 $1.53 Million - $1.88 Million	-244,400 Reduced 55.0%	200,000 $1.26 Million
Q1 2024 May 15, 2024	BUY	$5.47 - $11.38 $2.43 Million - $5.06 Million	444,400 New	444,400 $2.97 Million
Q1 2023 May 15, 2023	SELL	$6.65 - $10.69 $1.06 Million - $1.7 Million	-159,400 Reduced 32.65%	328,800 $2.42 Million
Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $2.31 Million - $3.31 Million	388,200 Added 388.2%	488,200 $4.15 Million
Q3 2022 Nov 14, 2022	BUY	$5.95 - $14.3 $434,945 - $1.05 Million	73,100 Added 271.75%	100,000 $616,000

170

153M

42.9K

82.4K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $6.76B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.